Early trial of new drug shows promise for patients with metastatic triple-negative breast cancer
Wednesday, December 10, 2014 - 16:32
in Health & Medicine
In patients with metastatic triple-negative breast cancer, infusion of pembrolizumab produced durable responses in almost one out of five patients. One of the 27 patients had a complete response and four had a partial response. Seven more patients had stable disease.